Primary biliary cholangitis (PBC) is a rare autoimmune cholestatic liver disease associated with a risk of developing cirrhosis and portal hypertension, as well as symptoms such as pruritus and ...

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and ...

Primary biliary cholangitis (PBC) is a rare liver disease. It blocks and destroys bile ducts in the liver. Doctors used to call it “primary biliary cirrhosis.” “Biliary” means bile. That ...

Your liver is one of the most vital organs, responsible for detoxification, digestion, and metabolism. However, liver damage can often go unnoticed until it reaches an advanced stage. Recognizing the ...

To mark World Down Syndrome Day on March 21, Fox News contributor Tom Shillue headed to Times Square to speak with a father of a girl with Down syndrome about common misperceptions.

Chronic hepatitis was the earliest alteration associated with the syndrome of "primary biliary cirrhosis" and was encountered two months after the clinical onset of disease in 1 patient (Case 22).

The main treatment for primary biliary cirrhosis is to slow liver damage with the drug ursodiol (Actigall, Urso). Ursodiol can cause side effects such as diarrhea, constipation, dizziness, and ...

The FDA has issued a safety alert warning that Ocaliva carries an increased risk for “serious liver injury” among patients with primary biliary cholangitis, even those without advanced cirrhosis.

Quality-of-Life Research in PBC Patients. One of the earliest studies to assess quality of life in patients with PBC included 276 British patients, mostly women, who had worse scores on overall ...

For more than a century physicians have been fascinated and frustrated by a rare clinicopathological syndrome characterized by chronic ... Primary Biliary Cirrhosis. Published November 26 ...

Spotlight On > AASLD: PBC Managing Primary Biliary Cholangitis Progression and Symptoms — Though only one approved agent has been available for decades, the armamentarium has expanded ...

The long-stagnant primary biliary cholangitis drug market has seen renewed attention in the past 3 months with the addition of two FDA-approved therapy options as well as a costly ruling from an ...